Amundi
PFE icon

Amundi’s Pfizer PFE Stock Holding History

Amundi’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$807M Sell
33,533,616
-7,291,854
-18% -$191M 0.19% 85
2026
Q1 		$1.15B Sell
40,825,470
-6,237,910
-13% -$166M 0.31% 59
2025
Q4 		$1.17B Buy
47,063,380
+5,572,451
+13% +$141M 0.32% 65
2025
Q3 		$1.1B Buy
41,490,929
+4,043,413
+11% +$99.8M 0.35% 57
2025
Q2 		$948M Sell
37,447,516
-14,642,887
-28% -$341M 0.33% 62
2025
Q1 		$1.27B Buy
52,090,403
+15,758,846
+43% +$412M 0.46% 43
2024
Q4 		$976M Sell
36,331,557
-10,800,352
-23% -$293M 0.34% 58
2024
Q3 		$1.38B Sell
47,131,909
-3,020,962
-6% -$88.1M 0.51% 39
2024
Q2 		$1.39B Buy
50,152,871
+3,797,029
+8% +$105M 0.53% 31
2024
Q1 		$1.19B Buy
46,355,842
+3,786,243
+9% +$105M 0.51% 31
2023
Q4 		$1.25B Buy
42,569,599
+4,034,449
+10% +$122M 0.56% 27
2023
Q3 		$1.24B Buy
38,535,150
+4,075,254
+12% +$144M 0.61% 23
2023
Q2 		$1.26B Sell
34,459,896
-613,986
-2% -$23.9M 0.64% 23
2023
Q1 		$1.46B Buy
35,073,882
+2,545,942
+8% +$110M 0.78% 18
2022
Q4 		$1.55B Buy
32,527,940
+779,617
+2% +$37.4M 0.85% 19
2022
Q3 		$1.4B Buy
31,748,323
+3,958,979
+14% +$192M 0.83% 17
2022
Q2 		$1.43B Buy
27,789,344
+2,149,041
+8% +$110M 1.15% 8
2022
Q1 		$1.41B Buy
25,640,303
+1,362,436
+6% +$70.7M 0.95% 11
2021
Q4 		$1.35B Buy
24,277,867
+4,235,747
+21% +$210M 0.86% 11
2021
Q3 		$862M Sell
20,042,120
-74,835
-0.4% -$3.32M 0.6% 26
2021
Q2 		$788M Buy
+20,116,955
New +$782M 0.55% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi's PFE Position: Q2 2026 in Review

Amundi reduced its Pfizer (PFE) stake by 18% in Q2 2026, selling an estimated $191M and leaving 33,533,616 shares worth $807M. The position accounts for 0.19% of the portfolio, ranked #85.

Amundi first reported a position in PFE in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.55B in Q4 2022. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Amundi held 33,533,616 shares of Pfizer worth $807M as of Q2 2026.
  • Amundi sold 7,291,854 Pfizer shares in Q2 2026, an estimated $191M.
  • Pfizer made up 0.19% of Amundi's portfolio in Q2 2026, its #85 holding.
  • Amundi first reported a position in Pfizer in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Pfizer position peaked at $1.55B in Q4 2022.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.